Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY: LH )

218.41 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 218.41
Bid (Size) 167.00 (1)
Ask (Size) 225.00 (1)
Prev. Close 218.41
Today's Range 218.41 - 218.41
52wk Range 200.32 - 280.72
Shares Outstanding 88,600,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Is Enzo Biochem (ENZ) Stock Up 72% Today?
Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH). 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
Via InvestorPlace

Performance

YTD
-8.15%
-8.15%
1 Month
-9.86%
-9.86%
3 Month
-6.25%
-6.25%
6 Month
+3.79%
+3.79%
1 Year
-20.99%
-20.99%

More News

Read More
Why Enzo Biochem Stock Is Skyrocketing After Hours
Via Benzinga
Where Laboratory Corp Stands With Analysts
Via Benzinga
Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
From Labcorp
Via Business Wire
Earnings Scheduled For February 16, 2023
Via Benzinga
Earnings Preview: Laboratory Corp
Via Benzinga
Hopeful Golden Cross Forms On Laboratory Corp's Chart
Via Benzinga
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
From Labcorp
Via Business Wire
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
From Labcorp
Via Business Wire
Down 40% in 2022, Can Exact Sciences Recover in 2023?
Via The Motley Fool
Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
From Labcorp
Via Business Wire
6 Analysts Have This to Say About Laboratory Corp
Via Benzinga
Analyst Ratings for Laboratory Corp
Via Benzinga
4 Analysts Have This to Say About Laboratory Corp
Via Benzinga
A Look Into Laboratory Corp's Debt
Via Benzinga
Labcorp Declares Quarterly Dividend
From Labcorp
Via Business Wire
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
From Labcorp
Via Business Wire
Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference
From Labcorp
Via Business Wire
Expert Ratings for Laboratory Corp
Via Benzinga
Why Jim Cramer Can't Recommend Investing In Carl Icahn's Company
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Labcorp Opens New Los Angeles Based Laboratory
From Labcorp
Via Business Wire
Laboratory Corp Earnings Perspective: Return On Capital Employed
Via Benzinga
Labcorp to Speak at the Credit Suisse 31st Annual Healthcare Conference
From Labcorp
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.